Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · August 26, 2022

Efficacy and Safety of Soticlestat Treatment as an Adjunctive Therapy in Pediatric Patients With Dravet Syndrome or Lennox–Gastaut Syndrome



Additional Info

A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA)
Epilepsia 2022 Jul 16;[EPub Ahead of Print], CD Hahn, Y Jiang, V Villanueva, M Zolnowska, D Arkilo, S Hsiao, M Asgharnejad, D Dlugos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading